Results 271 to 280 of about 3,112,739 (313)
Some of the next articles are maybe not open access.
Evaluation of whole blood immunoreactivity
Pirogov Russian Journal of SurgeryTo assess cellular immunoreactivity, lipopolysaccharide (LPS), Concanavalin A (Con A), or LPS together with Con A was added to the whole blood for 18 hours. LPS preferentially stimulated release of tumor necrosis factor-alfa (TNF-α), interleukin-6 (IL-6), IL-10 and vascular endothelial growth factor (VEGF) by blood cells, whereas Con A significantly ...
I.A. Seledtsova +3 more
openaire +2 more sources
Blood donor suitability and allogeneic whole blood donation**
Transfusion Medicine Reviews, 2001Blood donor suitability criteria are designed to protect both the blood donor and blood recipient from harm. The risks for allogeneic (community) whole blood donors who give blood and for blood recipients who receive it are described. Blood donor suitability criteria are based on science, informed medical opinion, and regulatory rules. The criteria for
openaire +2 more sources
Whole blood for old blood: Use of whole blood for resuscitation in older trauma patients
InjuryOlder patients are expected to comprise 40 % of trauma admissions in the next 30 years. The use of whole blood (WB) has shown promise in improving mortality while lowering the utilization of blood products. However, the use of WB in older trauma patients has not been examined.
Gregory R. Stettler +8 more
openaire +2 more sources
Spectrophotometry on whole blood
Scandinavian Journal of Clinical and Laboratory Investigation, 1955openaire +2 more sources
Strategies for delivering therapeutics across the blood–brain barrier
Nature Reviews Drug Discovery, 2021Georg C Terstappen, Wandong Zhang
exaly